IL1R1 and myeloid sarcoma: Importantly, expression of IL-1R1 in the in vivo-differentiated Th17 cells was higher in MS patients compared to healthy donors (Figure 4B), indicating that mechanisms leading to overexpression of IL-1R1 in MS also occur in vivo.